However, clinical data on the impact of menopause on AD risk in APOE3/3s are limited as the focus is typically on APOE4. In APOE3-TR mice, OVX reduced hippocampal spine density, long-term potentiation (22), and disrupted learning in MWM (55). Here, APOE is linked to Alzheimer disease.